(5-p-Tolyl-[1,2,4]oxadiazol-3-yl)-acetic acid ethyl ester, 95.0%, 500mg

Molekularsieb 4 Å, 0,4 nm, Typ 514, Perlform, 750 g, Glasverpackung

Methyl 2-bromo-4-methylthiazole-5-carboxylate, 95.0%, 1g

4-(2,5-Dioxo-imidazolidin-1-yl)-butyric acid, 100mg

3-(pyridin-3-yl)-1H-pyrazole-5-carboxamide, 95+%, 100mg

3-Amino-4-iodobenzotrifluoride, 95.0%, 25g

4-Chloropyrazolo[1,5-a]pyridine-3-carboxylic acid, 95.0%, 100mg

2-methyl-2-(4-morpholinyl)propanoic acid hydrochloride hydrate, 95.0%, 5g

tert-butyl 2,8-diazaspiro[4.6]undecane-2-carboxylate hydrochloride, 95.0%, 250mg

Diethyl-(2-nitro-4-trifluoromethyl-phenyl)-amine, 1g

[(2E)-2-methyl-3-phenylprop-2-en-1-yl](2-methylpropyl)amine, 95.0%, 10g

2-(1-Methylpyrrolidin-2-yl)ethanol, 97.0%, 25g

7-Bromo-3-methyl-1H-indole, 95.0%, 1g